acute lung injury
MeSH: D055371ORPHA: 1783201 Treatment Available
Overview
condition of lung damage characterized by bilateral pulmonary infiltrates
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Ravulizumab Orphan Cold Chain | IV infusion | FDA Approved | 4 | — |
Clinical Presentation
Signs and symptoms associated with acute lung injury, sourced from HPO and Orphanet clinical annotations.
PneumoniaDyspneaRespiratory distressPulmonary infiltratesTachypneaRespiratory failureAbnormal circulating cytokine concentrationElevated circulating C-reactive protein concentrationHypoxemiaIncreased circulating interleukin 6 concentrationElevated circulating surfactant protein concentrationEdemaAcute pancreatitisFeverHemoptysisAbnormal pulmonary interstitial morphologyAbnormality of tumor necrosis factor secretionDiffuse alveolar hemorrhageAddictive alcohol useShockSepsis
Classification & Codes
MeSH Code
D055371Orphanet Code
ORPHA:178320acute lung injury
| MeSH | D055371 |
| Orphanet | ORPHA:178320 |
| Treatments | 1 drug(s) |
| Symptoms on record | 21 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO